Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 2.09 | 15.47% | 0.28 |
ACRS closed up 15.47 percent on Friday, November 1, 2024, on 2.66 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Nov 4
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Parabolic Rise | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% |
| Alert | Time |
|---|---|
| Up 2 ATRs | about 22 hours ago |
| Up 10% | about 22 hours ago |
| 60 Minute Opening Range Breakout | about 23 hours ago |
| Rose Above Previous Day's High | about 23 hours ago |
| Outside Day | about 23 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.705 |
| 52 Week Low | 0.5902 |
| Average Volume | 472,316 |
| 200-Day Moving Average | 1.22 |
| 50-Day Moving Average | 1.26 |
| 20-Day Moving Average | 1.37 |
| 10-Day Moving Average | 1.57 |
| Average True Range | 0.12 |
| RSI (14) | 87.01 |
| ADX | 38.95 |
| +DI | 51.82 |
| -DI | 3.10 |
| Chandelier Exit (Long, 3 ATRs) | 1.77 |
| Chandelier Exit (Short, 3 ATRs) | 1.48 |
| Upper Bollinger Bands | 1.94 |
| Lower Bollinger Band | 0.80 |
| Percent B (%b) | 1.13 |
| BandWidth | 82.93 |
| MACD Line | 0.18 |
| MACD Signal Line | 0.10 |
| MACD Histogram | 0.0829 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.63 | ||||
| Resistance 3 (R3) | 2.58 | 2.36 | 2.54 | ||
| Resistance 2 (R2) | 2.36 | 2.22 | 2.38 | 2.51 | |
| Resistance 1 (R1) | 2.22 | 2.13 | 2.29 | 2.27 | 2.48 |
| Pivot Point | 2.00 | 2.00 | 2.03 | 2.02 | 2.00 |
| Support 1 (S1) | 1.86 | 1.86 | 1.93 | 1.91 | 1.70 |
| Support 2 (S2) | 1.64 | 1.77 | 1.66 | 1.67 | |
| Support 3 (S3) | 1.50 | 1.64 | 1.64 | ||
| Support 4 (S4) | 1.55 |
